Helen Schiltz

Dr. Helen Schiltz


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2014 in Viruses
Verified
Journal Article
Open access
PDF file
RHRona Hirschberg
Rona Hirschberg
LWLucy Ward
Lucy Ward
NKNicole Kilgore
Nicole Kilgore
RKRebecca Kurnat
Rebecca Kurnat
HSHelen Schiltz
Helen Schiltz
ENEd Nuzum
Ed Nuzum
On August 22–23, 2013, agencies within the United States Department of Defense (DoD) and the Department of Health and Human Services (HHS) sponsored the Filovirus Medical Countermeasures (MCMs) Workshop as an extension of the activities of the Filovirus Animal Non-clinical Group (FANG). The FANG is a federally-recognized multi-Agency group established in 2011 to coordinate and facilitate U.S. government (USG) efforts to develop filovirus MCMs. The workshop brought together government, academic and industry experts to consider the needs for filovirus MCMs and evaluate the status of the product development pipeline. This report summarizes speaker presentations and highlights progress and challenges remaining in the field.

8 November 2019 in Vaccines
Verified
Journal Article
Open access
PDF file
KTKay Tomashek
Kay Tomashek
MCMark Challberg
Mark Challberg
SNSeema U. Nayak
Seema U. Nayak
HSHelen Schiltz
Helen Schiltz
Yellow fever is a potentially fatal, mosquito-borne viral disease that appears to be experiencing a resurgence in endemic areas in Africa and South America and spreading to non-endemic areas despite an effective vaccine. This trend has increased the level of concern about the disease and the potential for importation to areas in Asia with ecological conditions that can sustain yellow fever virus transmission. In this article, we provide a broad overview of yellow fever burden of disease, natural history, treatment, vaccine, prevention and control initiatives, and vaccine and therapeutic agent development efforts.